US Nationwide Insight Into All-cause 30-day Readmissions following Inpatient Endoscopic Retrograde Cholangiopancreatography
EndoscopyResearchPublications

US Nationwide Insight Into All-cause 30-day Readmissions following Inpatient Endoscopic Retrograde Cholangiopancreatography

Dr. Kalpit DevaniJanuary 1, 20231 min read

Publication Information

Journal: Journal of Clinical Gastroenterology

Year: 2023

Authors: Radadiya D, Devani K, Ashhab A, Gaisinskaya P, Charilaou P, Reddy C, Gaddam S

PMID: 35537131

DOI: 10.1097/MCG.0000000000001709

View on PubMed
US Nationwide Insight Into All-cause 30-day Readmissions following Inpatient Endoscopic Retrograde Cholangiopancreatography - Medical Research

Related medical research illustration

Overview


US nationwide analysis of all-cause 30-day readmissions following inpatient ERCP.


Publication Details


**Journal:** Journal of Clinical Gastroenterology

**Year:** 2023

**Authors:** Radadiya D, Devani K, Ashhab A, Gaisinskaya P, Charilaou P, Reddy C, Gaddam S


**PMID:** 35537131

**DOI:** 10.1097/MCG.0000000000001709



Key Findings


This publication contributes to the field of gastroenterology and hepatology, providing valuable insights into gastrointestinal health. The research methodology and findings offer important implications for clinical practice and patient care.


Clinical Significance


The findings from this study have significant implications for:

- Clinical decision-making in gastroenterology

- Patient care and treatment protocols

- Future research directions in the field


Access the Full Publication


For the complete research article, detailed methodology, and comprehensive results, please refer to the original publication.


Read Full Article on PubMed


This blog post summarizes a peer-reviewed publication by Dr. Kalpit Devani and colleagues. For detailed information, please refer to the original publication.

Share: